Intellia Therapeutics, Inc. (NTLA)
12.89
-0.60
(-4.45%)
USD |
NASDAQ |
Jun 09, 16:00
12.97
+0.08
(+0.62%)
After-Hours: 20:00
Intellia Therapeutics SG&A Expense (Quarterly) : 34.84M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 34.43M |
| Twist Bioscience Corp. | 76.08M |
| Tenaya Therapeutics, Inc. | 5.447M |
| HCW Biologics Inc. | 1.833M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |